Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12

Journal of Leukocyte Biology

Volumn 64, Issue 3, 1998, Pages 384-392

  Kanegane, Chiharu ^a   Sgadari, Cecilia ^a   Kanegane, Hirokazu ^a   Teruya Feldstein, Julie ^b   Yao, Lei ^a   Gupta, Ghanshyam ^a   Farber, Joshua M ^c   Liao, Fang ^c   Liu, Li ^d   Tosato, Giovanna ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d BD Technologies   (United States)

Author keywords

Athymic mice, angiogenesis; Burkitt lymphoma; Cancer treatment

Indexed keywords

INTERFERON INDUCING AGENT; INTERLEUKIN 12; NEUTRALIZING ANTIBODY;

ANGIOGENESIS; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BURKITT LYMPHOMA; GROWTH INHIBITION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR IMMUNITY; TUMOR VOLUME;

ANIMALIA; MUS MUSCULUS;

EID: 0031656897     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.64.3.384     Document Type: Article

References (42)

1. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Shennan, F., Perussia, B., Trinchieri, G. (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827-845.
2. Stern, A. S., Podlaski, F. J., Hulmes, J. D., Pan, Y. E., Quinn, P. M., Wolitzky, A. G., Familletti, P. C., Stremlo, D. L., Truitt, T., Chizzonite, R., Gately, M. K. (1990) Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87, 6808-6812.
3. Gubler, U., Chua, A. O., Schoenhaut, D. S., Dwyer, C. M., McComas, W., Motyka, R., Nabavi, N., Wolitzky, A. G., Quinn, P. M., Familletti, P. C., Gately, M. K. (1991) Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88, 4143-1147.
4. Wolf, S. F., Temple, P. A., Kobayashi, M., Young, D., Dicig, M., Lowe, L., Dzialo, R., Fitz, L., Ferenz, C., Hewick, R. M., Kelleher, K., Hermann, S. H., Clark, S. C., Azzoni, L., Chan, S. H., Trinchieri, G., Perussia, B. (1991) Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146, 3074-3081.
5. Schoenhaut, D. S., Chua, A. O., Wolitzky, A. G., Quinn, P. M., Dwyer, C. M., McComas, W., Familletti, P. C., Gately, M. K., Gubler, I. (1992) Cloning and expression of murine IL-12. J. Immunol. 148, 3433-3440.
6. D'Andrea, A., Rengaraju, M., Valiante, N. M., Chehimi, J., Kubin, M., Aste, M., Chan, S. H., Kobayashi, M., Young, D., Nickbarg, E, Chizzonite, R., Wolff, S. F., Trinchieri, G. (1992) Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176, 1387-1398.
7. Gately, M. K., Desai, B. B., Wolitzky, A. G., Quinn, P. M., Dwyer, C. M., Podlaski, F. J., Familletti, P. C., Sinigaglia, F. Chizzonite, R., Gubler, U. (1991) Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147, 874-882.
8. Zeh, H. J., Hurd, S., Storkus, W. J., Lotze, M. T. (1993) Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer. J. Immunother. 14, 155-159.
9. Chan, S. H., Kobayashi, M., Santoli, D., Perussia, B., Trinchieri, G. (1992) Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12): role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J. Immunol. 148, 92-98.
10. Gately, M. K., Warner, R. R., Honasoge, S., Carvajal, D. M., Faherty, D. A., Connaughton, S. E., Anderson, T. D., Sarmiento, U., Hubbard, B. R. (1994) Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. Int. Immunol. 6, 157-167.
11. Manetti, R., Parronchi, P., Giudizi, M. G., Piccinni, M. P., Maggi, E., Trinchieri, G., Romagnani, S. (1993) Natural killer cell stimulatory (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177, 1199-1204.
12. + T cells through IL-12 produced by Liberia-induced macrophages. Science 260, 547-549.
13. Heinzel, F. P., Schoenhaut, D. S., Rerko, R. M., Rosser, L. E., Gately, M. K. (1993) Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177, 1505-1509.
14. Tripp, C. S., Wolf, S. F., Unanue, E. R. (1993) Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Nad. Acad. Sci. USA 90, 3725-3729.
15. Wynn, T. A., Jankovic, D., Hieny, S., Cheever, A. W., Sher, A. (1994) Endogenous IL-12 regulates granuloma formation induced by eggs of schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 179, 1551-1561.
16. Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., Gately, M. K. (1993) Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178, 1223-1230.
17. Nastala, C. L., Edington, H. D., McKinney, T. G., Tahara, H., Nalesnik, M. A., Brunda, M. J., Gately, M. K., Wolf, S. F., Schreiber, R. D., Storkus, W. J., Lotze, M. T. (1994) Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153, 1697-1706.
18. Voest, E. E., Kenyon, B. M., O'Reilly, M. S., Truitt, G., D'Amato, R. J., Folkman, J (1995) Inhibition of angiogenesis in vivo by interleukin 12. Natl. Cancer Inst. 87, 581-586.
19. Kerbel, R. S., Hawley, R. G. (1995) Interleukin 1. Newest member of the antiangiogenesis club. J. Natl. Cancer Inst. 87, 557-559.
20. Sgadari, C., Angiolillo, A. L., Tosato, G (1996) Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood 87, 3877-3882.
21. Amichay, D., Gazzinelli, R. T., Karupiah G., Moench, T. R., Sher, A., Farber, J. M. (1996) Genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-γ with patterns of tissue expression that suggest nonredundant roles in vivo. J. Immunol. 157, 4511-1520.
22. Angiolillo, A. L., Sgadari, C., Angiolillo, A., Taub, D. D., Liao, F., Farber, J. M., Maheshwari, S., Kleinman, H. K., Tosato, G (1995) Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182, 155-162.
23. Stricter, R. M., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Polverini, P. J. (1995) Interferon γ-inducible protein 10 (IP-10), a member of the -C-X-C-chemokine family, is an inhibitor of angiogenesis. Biochem. Biophys. Res. Comm. 210, 51-57.
24. Luster, A. D., Leder, P. (1993) IP-10, a -C-X-C-chemokine, elicits a potent thymus-dependent antitumor response in vivo. J. Exp. Med. 178, 1057-1065.
25. Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Morris, S. B., Burdick, M. D., Glass, M. C., Taub, D. T., Iannettoni, M. D., Whyte, R. I., Strieter, R. M (1996) Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J. Exp. Med. 184, 981-992.
26. Sgadari, C., Angiolillo, A. L., Cherney, B. W., Pike, S. E., Farber, J. M., Koniaris, L. G., Vanguri, P., Burd, P. R., Sheikh, N., Gupta, G., Feldstein, J. T., Tosato, G. (1996) Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. Proc. Natl. Acad. Sci. USA 93, 13791-13796.
27. Liao, F., Rabin, R. L., Yannelli, J. R., Koniaris, L., Vanguri, P., Farber, J. M. (1995) Human Mig chemokine: biochemical and functional characterization. J. Exp. Med. 182, 1301-1314.
28. Strieter, R. M., Polverini, P. J., Arenberg, D. A., Kunkel, S. K. (1995) The role of CXC chemokines as regulators of angiogenesis. Shock 4, 155-160.
29. Sgadari, C., Farber, J. M., Angiolillo, A. L., Liao, F., Feldstein, J. T., Burd, P. R., Yao, L., Gupta, G., Kanegane, C., Tosato, G. (1997) Mig, the monokine induced by IFN-γ, promotes tumor necrosis in vivo. Blood 89, 2635-2643.
30. Teruya-Feldstein, J., Jaffe, E., Burd, P. R., Kanegane, H., Kingma, D. W., Wilson, W. H., Longo, D. L., Tosato, G. (1997) The role of Mig, the monokine induced by interferon-and IP-10, the Interferon-γ-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood 90, 4099-4105.
31. Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A. Marriott, D., Chan, S. Y., Roczniak, S., Shanafelt, A. B. (1995) The functional role of the ELR motif in C-X-C-chemokine-mediated angiogenesis. J. Biol. Chem. 270, 27348-27357.
32. Luster, A. D., Greenberg, S. M., Leder, P. (1995) The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med. 182, 219-231.
33. Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M., Moser, B. (1996) Chemokine receptor specific for IP-10 and Mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184, 963-969.
34. Taga, K., Yamauchi, A., Kabashima, K., Bloom, E., Muller, J., Tosato, G. (1996) Target-induced death by apoptosis in human lymphokine-activated natural killer cells. Blood 87, 2411-2418.
35. Stuehr, D. L., Nathan, C. F. (1989) Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169, 1543-1555.
36. Tsung, K., Meko, J. B., Peplisnski, G. R., Tsung, Y. L., Norton, J. A. (1997) IL-12 induces helper 1-directed anti-tumor response. J. Immunol. 158, 3359-3365.
37. Medler, R. J., Koenig, G. C., Witwer, B. P., Safabakhsh, N., Munn, L. L., Jain, R. K. (1996) During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nature Med. 2, 992-997.
38. Rosenberg, S. (1990) Adoptive immunotherapy for cancer. Scientific Am. 262, 62-69.
39. Ferrara, N. (1996) Natural killer cells, adhesion and tumor angiogeneis. Nature Med. 2, 971-972.
40. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1, 27-31.
41. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164.
42. Huang, X., Molema, G., King, S., Watkins, L., Edgington, T. S., Thorpe, P. E. (1997) Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science 275, 547-550.